Form4insider filings, from the source

SEC Form 3 · accession 0001250853-18-000106

Bone Biologics Corp · BBLG

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Don Hankey
Officer — Chairman of the Board · Director · 10% Owner
Period of report
Jul 16, 2018
Accepted (ET)
Jul 26, 2018 · 7:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419554

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F8holding———3,865,058IBy Hankey Capital, LLC
Common StockF1,F3,F8holding———1,139,240IBy Hankey Capital, LLC
Common StockF1,F4holding———361,640IBy Don Hankey Trust
Common StockF1,F5holding———274,240IBy H&H Funding LLC

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Convertible NotesF6,F1,F7$1.00holding————Dec 31, 2019Common Stock7,860,760—I
WarrantsF6,F1$15.80holding————Oct 23, 2019Common Stock237,342—I
WarrantsF6,F1$15.80holding————May 4, 2020Common Stock174,051—I
WarrantsF6,F1$20.50holding————Feb 23, 2021Common Stock146,342—I

Explanation of responses